These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13). Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN J Antimicrob Chemother; 2015 Feb; 70(2):498-504. PubMed ID: 25362568 [TBL] [Abstract][Full Text] [Related]
11. [Glycopeptide heteroresistance and tolerance in hospital grampositive isolates: "invisible" phenomena to the clinician with clinical implications?]. Aguilar L; Giménez MJ; Barberán J Rev Esp Quimioter; 2009 Dec; 22(4):173-9. PubMed ID: 20082037 [TBL] [Abstract][Full Text] [Related]
12. Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Streit JM; Fritsche TR; Sader HS; Jones RN Diagn Microbiol Infect Dis; 2004 Feb; 48(2):137-43. PubMed ID: 14972384 [TBL] [Abstract][Full Text] [Related]
13. In vitro study to evaluate the sensitivity to daptomycin among gram positive clinical isolates. Padmaja K; Umabala P; Prasad KS; Lakshmi V Indian J Med Microbiol; 2012; 30(1):114-5. PubMed ID: 22361779 [No Abstract] [Full Text] [Related]
14. In-vitro activity of LY264826, an investigational glycopeptide antibiotic, against gram-positive bloodstream isolates and selected gram-negative bacilli. Perl TM; Wenzel RP; Jones RN J Antimicrob Chemother; 1992 May; 29(5):596-8. PubMed ID: 1624399 [No Abstract] [Full Text] [Related]
15. Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014. Pfaller MA; Sader HS; Flamm RK; Castanheira M; Mendes RE Diagn Microbiol Infect Dis; 2018 Jun; 91(2):199-204. PubMed ID: 29567128 [TBL] [Abstract][Full Text] [Related]
16. Glycopeptide antibiotic analogs for selective inactivation and two-photon imaging of vancomycin-resistant strains. Ariyasu S; Too PC; Mu J; Goh CC; Ding Y; Tnay YL; Yeow EK; Yang L; Ng LG; Chiba S; Xing B Chem Commun (Camb); 2016 Mar; 52(25):4667-70. PubMed ID: 26953360 [TBL] [Abstract][Full Text] [Related]